eCite Digital Repository
Pharmacological inhibition of store-operated calcium entry in MDA-MB-468 basal A breast cancer cells: consequences on calcium signalling, cell migration and proliferation
Citation
Azimi, I and Bong, AH and Poo, GXH and Armitage, K and Lok, D and Roberts-Thomson, SJ and Monteith, GR, Pharmacological inhibition of store-operated calcium entry in MDA-MB-468 basal A breast cancer cells: consequences on calcium signalling, cell migration and proliferation, Cellular and Molecular Life Sciences, 75, (24) pp. 4525-4537. ISSN 1420-682X (2018) [Refereed Article]
Copyright Statement
© Springer Nature Switzerland AG 2018
DOI: doi:10.1007/s00018-018-2904-y
Abstract
Store-operated Ca2+ entry is a pathway that is remodelled in a variety of cancers, and altered expression of the components of store-operated Ca2+ entry is a feature of breast cancer cells of the basal molecular subtype. Studies of store-operated Ca2+ entry in breast cancer cells have used non-specifc pharmacological inhibitors, complete depletion of intracellular Ca2+ stores and have mostly focused on MDA-MB-231 cells (a basal B breast cancer cell line). These studies compared the efects of the selective store-operated Ca2+ entry inhibitors Synta66 and YM58483 (also known as BTP2) on global cytosolic free Ca2+ ([Ca2+]CYT) changes induced by physiological stimuli in a diferent breast cancer basal cell line model, MDA-MB-468. The efects of these agents on proliferation as well as serum and epidermal growth factor (EGF) induced migration were also assessed. Activation with the purinergic receptor activator adenosine triphosphate, produced a sustained increase in [Ca2+]CYT that was entirely dependent on store-operated Ca2+ entry. The protease activated receptor 2 activator, trypsin, and EGF also produced Ca2+ infux that was sensitive to both Synta66 and YM58483. Serum-activated migration of MDA-MB-468 breast cancer cells was sensitive to both store-operated Ca2+ inhibitors. However, proliferation and EGF-activated migration was diferentially afected by Synta66 and YM58483. These studies highlight the need to defne the exact mechanisms of action of diferent store-operated calcium entry inhibitors and the impact of such diferences in the control of tumour progression pathways.
Item Details
| Item Type: | Refereed Article |
|---|---|
| Keywords: | pharmacology, cancer, Orai1, store-operated calcium entry, Synta66, YM58483 |
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Pharmacology and pharmaceutical sciences |
| Research Field: | Basic pharmacology |
| Objective Division: | Expanding Knowledge |
| Objective Group: | Expanding knowledge |
| Objective Field: | Expanding knowledge in the biological sciences |
| UTAS Author: | Azimi, I (Dr Iman Azimi) |
| ID Code: | 127768 |
| Year Published: | 2018 |
| Web of Science® Times Cited: | 46 |
| Deposited By: | Pharmacy |
| Deposited On: | 2018-08-15 |
| Last Modified: | 2019-03-05 |
| Downloads: | 0 |
Repository Staff Only: item control page